Related Experiment Video
Updated: Jun 23, 2025
10:35
Measuring the Stiffness of Ex Vivo Mouse Aortas Using Atomic Force Microscopy
Published on: October 19, 2016
10.5K
Arterial Stiffness and Heart Failure With Preserved Ejection Fraction
1Division of Cardiology, Department of Internal Medicine, Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea.
Journal of Korean Medical Science
|June 18, 2024
Summary
Arterial stiffness is a key factor in heart failure with preserved ejection fraction (HFpEF), impacting diagnosis and outcomes. Reducing arterial stiffness may improve diastolic function and patient prognosis in HFpEF.
Area of Science:
- Cardiovascular Medicine
- Vascular Biology
- Gerontology
Background:
- Heart failure with preserved ejection fraction (HFpEF) is common and has a poor prognosis.
- Arterial stiffness, a marker of vascular aging, is increasingly implicated in HFpEF pathophysiology.
- HFpEF is associated with cardiovascular risk factors like hypertension, diabetes, and obesity.
Purpose of the Study:
- To explore the role of arterial stiffness in the pathophysiology of HFpEF.
- To highlight the diagnostic and prognostic value of arterial stiffness in HFpEF.
- To review potential interventions targeting arterial stiffness for HFpEF management.
Main Methods:
- Literature review of studies investigating arterial stiffness in HFpEF.
- Analysis of the relationship between arterial stiffness and cardiovascular risk factors.
- Examination of intervention studies targeting arterial stiffness.
Main Results:
- Patients with HFpEF show significantly higher arterial stiffness than controls.
- Arterial stiffness contributes to increased left ventricular afterload and diastolic dysfunction.
- Interventions reducing arterial stiffness may improve diastolic function and outcomes.
Conclusions:
- Arterial stiffness is a critical factor in HFpEF, influencing diagnosis, management, and prognosis.
- Further research is needed to fully elucidate the mechanisms linking arterial stiffness to HFpEF.
- Targeting arterial stiffness presents a promising therapeutic strategy for HFpEF.
Related Concept Videos
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
01:26Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
420
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
420
01:22Heart Failure Drugs: Diuretics
363
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
363
01:17Ischemic Heart Disease: Overview
1.3K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K
01:26Heart Failure Drugs: Inotropic Agents
564
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
564